John D. Bluth
Public Communications Contact chez BIOCRYST PHARMACEUTICALS, INC.
Profil
John D.
Bluth is currently the Chief Communications Officer at BioCryst Pharmaceuticals, Inc. Prior to his current position, he held the role of Director-Investor Relations at CV Therapeutics, Inc. From 2012 to 2016, he served as the SVP-Investor Relations & Corporate Communications at PowerSecure International, Inc. He also held the positions of EVP-Investor Relations & Corporate Communications at both Cempra, Inc. and Melinta Therapeutics, Inc. Before that, from 2009 to 2012, he was the SVP-Investor Relations & Group Communications at Elster Group SE.
Mr. Bluth completed his undergraduate degree at Cornell University.
Postes actifs de John D. Bluth
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Public Communications Contact | 01/04/2019 |
Anciens postes connus de John D. Bluth
| Sociétés | Poste | Fin |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Investor Relations Contact | 31/12/2017 |
| POWERSECURE INTERNATIONAL, INC. | Investor Relations Contact | 01/01/2016 |
Elster Group SE
 Elster Group SE Industrial MachineryProducer Manufacturing Elster Group SE provided electricity, gas and water measurement and control services. The firm offered distribution monitoring and control, advanced smart metering, demand response, networking and software solutions, and related communications and services. The company was founded on October 4, 2004 and was headquartered in Mainz-Kastel, Germany. | Investor Relations Contact | 01/01/2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Investor Relations Contact | 02/05/2011 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Investor Relations Contact | - |
Formation de John D. Bluth
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
PowerSecure International, Inc.
 PowerSecure International, Inc. Electrical ProductsProducer Manufacturing PowerSecure International, Inc. engages in the business of providing energy technologies and services to electric utilities and large industrial, commercial, institutional and municipal customers. It provides products and services through four reporting segments: distributed generation, solar energy, utility infrastructure, and energy efficiency. The company was founded by Sidney Hinton on April 5, 1991 and is headquartered in Wake Forest, NC. | Producer Manufacturing |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Elster Group SE
Elster Group SE Industrial MachineryProducer Manufacturing Elster Group SE provided electricity, gas and water measurement and control services. The firm offered distribution monitoring and control, advanced smart metering, demand response, networking and software solutions, and related communications and services. The company was founded on October 4, 2004 and was headquartered in Mainz-Kastel, Germany. | Producer Manufacturing |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
